Business Context and Reporting Period
Company: AptarGroup, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2004
Business Overview: AptarGroup is a leading global supplier of innovative dispensing systems (pumps, closures, and aerosol valves) for personal care, fragrance/cosmetic, pharmaceutical, household, and food/beverage markets. The company operates through two reportable segments: Dispensing Systems (aggregating four business units) and SeaquistPerfect (aerosol valves and certain pumps). Operations are global, with significant manufacturing and sales in Europe (61% of 2004 net sales).
Key Financial Metrics
| Metric | 2004 | 2003 | 2002 |
|---|---|---|---|
| Net Sales | $1,296.6 million | $1,114.7 million | $926.7 million |
| Operating Income | $140.9 million | $123.9 million | $107.1 million |
| Net Income | $93.3 million | $79.7 million | $66.6 million |
| Diluted EPS | $2.51 | $2.16 | $1.82 |
| Operating Margin | 10.9% | 11.1% | 11.6% |
| Net Profit Margin | 7.2% | 7.1% | 7.2% |
| Cash Flow from Operations | $183.2 million | $139.8 million | $154.5 million |
| Capital Expenditures | $119.7 million | $77.3 million | $89.8 million |
| Total Assets | $1,374.0 million | $1,264.3 million | $1,047.7 million |
| Long-Term Obligations | $142.6 million | $125.2 million | $219.2 million |
| Net Debt | $35.5 million | $56.9 million | $136.7 million |
| Stockholders' Equity | $873.2 million | $783.1 million | $594.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 16.3% to $1.297 billion. Approximately 7% of this increase was attributable to the weakening U.S. dollar against the Euro. Organic growth (excluding currency) was approximately 9%.
- Profitability: Operating income rose 13.7% to $140.9 million. However, operating margin declined slightly to 10.9% from 11.1% due to rising raw material costs, higher quality-related costs, and increased sales of lower-margin custom tooling.
- Cost of Sales: Increased to 66.8% of net sales (from 65.7% in 2003). Key drivers included a $1.5 million quality issue with pharmaceutical resin, $3.1 million in shutdown expenses for a U.S. mold facility, and rising raw material costs (plastic resin and metal).
- Segment Performance:
- Dispensing Systems: Sales grew 17.6% to $1.089 billion; Segment Income grew 13.3% to $142.6 million.
- SeaquistPerfect: Sales grew 10.1% to $207.4 million; Segment Income grew 16.8% to $18.1 million, driven by U.S. volume and new accessories.
- Balance Sheet: Net debt decreased significantly to $35.5 million (from $56.9 million) as the company utilized strong operating cash flow to pay down debt and repurchase stock.
Guidance, Outlook, and Risks
- 2005 Outlook: Management expects sales to continue growing across all markets but anticipates a challenging year due to competitive pricing and rising raw material costs. Diluted EPS for Q1 2005 is projected between $0.58 and $0.63.
- Acquisition: In February 2005, the company agreed to acquire EP Spray Systems SA (Switzerland) for approximately $29 million to add bag-on-valve technology.
- Capital Allocation: The company plans to spend approximately $95 million on capital expenditures in 2005. It also intends to repatriate approximately $32 million of foreign earnings in 2005.
- Key Risks:
- Currency: Significant exposure to the Euro; a strengthening Euro increases costs for European-produced goods sold in weaker currencies.
- Competition: Intense price competition, particularly from low-cost Asian suppliers in the fragrance/cosmetic and closure markets.
- Raw Materials: Volatility in plastic resin and metal prices, with potential delays in passing costs to customers.
- Goodwill Impairment: Approximately $95 million of goodwill in one reporting unit has a relatively small excess of fair value over carrying value; a 33% reduction in estimated cash flows could trigger an impairment test.
Investor Verification Checklist
- Raw Material Pass-Through: Verify the company's ability to pass on increased plastic and metal costs to customers without losing volume.
- Quality Control: Monitor the resolution of the pharmaceutical resin quality issue and the impact of the $2.7 million in quality-related charges on future margins.
- Currency Hedging: Review the effectiveness of forward exchange contracts in mitigating the impact of Euro fluctuations on operating margins.
- Goodwill Valuation: Assess the sensitivity of the $95 million goodwill balance in the specific reporting unit to changes in cash flow projections.
- Acquisition Integration: Track the closing and integration progress of the EP Spray Systems SA acquisition.